Waltham biotech Checkpoint Therapeutics stops cancer study due to Ukraine war


A Waltham biotech is stopping a late-stage clinical trial of a cancer drug because of the ongoing war in Ukraine.

Previous Vyant Bio cancels investor call over 'recent developments' with the potential sale of subsidiary
Next UofL Health – Jewish Hospital names new C-suite leader